scispace - formally typeset
P

Pengying Liao

Researcher at Chinese Academy of Sciences

Publications -  7
Citations -  178

Pengying Liao is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Panax notoginseng & Dammarane. The author has an hindex of 6, co-authored 7 publications receiving 158 citations.

Papers
More filters
Journal ArticleDOI

The processing of Panax notoginseng and the transformation of its saponin components

TL;DR: In this paper, HPLC analyses on saponin composition of processed notoginseng were conducted, which revealed that, during the steaming process, the five main ginsenosides (ginsenosides Rg(1), Rb-1, Rd, and Re, and notogsenoside R-1) decreased gradually and some other new saponins were formed.
Journal ArticleDOI

Dammarane-Type Glycosides from Steamed Notoginseng

TL;DR: Detailed chemical investigation on steamed notoginseng led to the isolation of 27 dammarane-type triterpenoids, including 4 new glycosides, namely,Notoginsenosides ST-1-ST-3 and ST-5 (1-4), in addition to 3 other known compounds, which possess new aglycones.
Journal ArticleDOI

Notoginsenoside ST-4 inhibits virus penetration of herpes simplex virus in vitro.

TL;DR: Notoginsenoside ST-4 was investigated for its antiviral activity on herpes simplex type 1 (HSV-1) and type 2 ( HSV-2) in vitro and it was confirmed by fluorescence microscopy observation that notoginseno-ST-4 blocked the penetration of virus.
Patent

Cooked Panax notoginseng and cooked Panax notoginseng standard extract and application thereof

TL;DR: In this article, a traditional Chinese medicine decoction piece with special chemical composition and a prepared notoginseng standard extract PNS450 obtained through further extraction of the prepared notogseng was provided.
Patent

Panax notoginseng saponins ST-4, and medicinal composition, preparation and use thereof

TL;DR: In this article, a dammarane type triterpenoid saponin compound, called notoginsenoside ST-4, is proposed for the preparation of drugs against HSV-1.